Sign in Subscribe
Cancer

Gene Editing Breakthrough in Gastric Cancer: Enhancer Remodeling and Cancer Cachexia

Strategic Insights

— 1 min read

Fresh data on gene editing in gastric cancer have been presented by researchers from Chongqing University, shedding light on the enhancer landscape marked by histone H3K27ac modifications in diffuse-type gastric cancer tissues. The study aimed to elucidate the epigenetic remodeling mechanisms by which active enhancers regulate cachexia-related genes. The research revealed significant differential enhancer regions between DGC and normal gastric mucosa tissues, and DGC tissues exhibited a marked increase in enhancer abundance. The study concluded that DGC exhibits enhancer remodeling, which regulates the expression of the cachexia-associated gene GDF15, and thereby contributes to the pathogenesis and progression of cancer cachexia.

Key Takeaways:

  • Researchers from Chongqing University identified significant differential enhancer regions between diffuse-type gastric cancer (DGC) and normal gastric mucosa tissues.
  • DGC tissues exhibited a marked increase in enhancer abundance, suggesting an association with cancer cachexia.
  • The study employed CRISPR-dCas9 gene editing technology to intervene with enhancers and detected the expression of target genes with Western blotting and qRT-PCR.
  • Sixteen female BALB/c Nude mice were used to establish an orthotopic xenograft tumor model using the human diffuse-type gastric cancer cell line MKN45.
  • Cachexia-related phenotypes were evaluated in three groups: normal group, silencing group, and control group.
  • The research concluded that enhancer remodeling in DGC contributes to the regulation of cachexia-associated genes, such as GDF15.
  • The study provides new insights into the epigenetic mechanisms underlying cancer cachexia in gastric cancer.

Statistics:

  • Sixteen female SPF-grade BALB/c Nude mice were utilized to establish an orthotopic xenograft tumor model.
  • 10 normal gastric mucosa tissues and 10 DGC tissues diagnosed with cachexia were collected from the Department of Gastroenterology of Army Medical Center of PLA.
  • 10 organoids derived from DGC tissues were used in the study.
  • CRISPR-dCas9 gene editing technology was used to intervene with enhancers in DGC tissues.
  • Western blotting and qRT-PCR were used to detect the expression of target genes.

Sources:

  • lujunjunyidaxuexuebao. 2025,47(11):1165-1176.
  • DOI: 10.16016/j.2097-0927.202502039.
  • https://doi-org.sdpl.idm.oclc.org/10.16016/j.2097-0927.202502039.
  • Editorial Office of Journal of Army Medical University.
  • TAN Yuting, School of Medicine, Chongqing University, Chongqing.
  • WU Linyu, PAN Yuwei.

Read more